Continuous venovenous hemofiltration for acute renal failure in a patient with congestive heart failure - Case report;Premoštenje razdoblja do transplantacije srca kontinuiranom venovenskom hemofiltracijom u bolesnika sa završnim stupnjem zatajenja srca I akutnim zatajenjem bubrega

Acta Medica Croatica

Volumn 57, Issue 4, 2003, Pages 319-322

  Brunetta, Bruna ^a   Bašić Jukić, Nikolina ^a   Kes, Petar ^a,b  

^a KBC Zagreb   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Acute renal failure; Congestive heart failure; Continuous veno venous hemofiltration; Heart transplantation

Indexed keywords

ACUTE KIDNEY FAILURE; ARTICLE; CARDIOMYOPATHY; CASE REPORT; CONGESTIVE HEART FAILURE; CONTINUOUS HEMOFILTRATION; DISEASE COURSE; HEART TRANSPLANTATION; HEMODYNAMIC MONITORING; HEMOFILTRATION; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; PREOPERATIVE TREATMENT;

EID: 0242386459     PISSN: 13300164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Francis GS, Goldsmith SR, Levine TB, Olivari MT, Cohn JN. The neuro-humoral axis in congestive heart failure. Ann Intern Med 1984; 10: 370-7.
2. Cody RJ, Covit AB, Schaer JH, Laragh JH, Sealey JE, Feldschuh J. Sodium and water balance in congestive heart failure. J Clin Invest 1986; 77: 1441-52.
3. Osterziel KJ, Dietz R. Should ACE-inhibitors be used for the treatment of heart failure in patients with depressed renal function? J Nephrol 1994; 7: 308-12.
4. Opie LH. The neuroendocrinology of congestive heart failure. Cardiovasc J S Afr 2002; 13(4): 171-8.
5. Luzza F, Bruni F, Rizzo F, Carerj S. Pathophysiology of congestive heart failure. Minerva Cardioangiol 2002; 50(3): 209-19.
6. Hensen J, Abraham WT, Lesnefsky EJ i sur. Atrial natriuretic peptide kinetic studies in patients with cardiac dysfunction. Kidney Int 1992; 42: 1333-9.
7. Kishimoto I, Saito Y, Li Y, Nakao K. Cross-talk between the natriuretic peptide system and the angiotensin system. Nippon Rinsho 2002; 60(10): 1923-8.
8. Badr KF, Ichikawa I. Prerenal failure: a deleterious shift from renal compensation to decompensation. N Engl J Med 1988; 319: 623-9.
9. Brater DC. Resistance to loop diuretics: why it happens and what to do about it. Drugs 1985; 30: 425-77.
10. Rose DB. Diuretics. Kidney Int 1991; 39: 336-52.
11. Bulow HH, Ladefoged SD. Loop diuretics. Rational pharmacotherapy. Ugeskr Laeger 1993; 155(44): 3563-6.
12. Ravnan SL, Ravnan MC, Deedwania PC. Pharmacotherapy in congestive heart failure: diuretic resistance and strategies to overcome resistance in patients with congestive heart failure. Congest Heart Fail 2002; 8(2): 80-5
13. Stanton BA, Kaisseing B. Adaptation of distal tubule and collecting ducts to increased Na delivery. II. Na+ and K+ transport. Am J Physiol 1988; 255: F1269-75.
14. Forslund T, Riddervold F, Fauchald P, Torvik D, Fyhrquist F, Simonen S. Hormonal changes in patients with severe chronic congestive heart failure treated by ultrafiltration. Nephrol Dial Transplant 1992; 7: 306-10.
15. Marenzi G, Grazi S, Giraldi F i sur. Interrelation of humoral factors, hemodynamics, and fluid and salt metabolism in congestive heart failure: effects of extracorporeal ultrafiltration. Am J Med 1993; 94: 49-56.
16. Coraim FI, Wolner E. Continuous hemofiltration for the failing heart. New Horizons 1995; 3: 725-31.
17. Millar AB, Armstrong L, Van der Linden i sur. Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass. Ann Thorac Surg 1993; 56: 1499-502.
18. Schnetz M, Krafft P, Boehrer H i sur. Removal of cytokines in septic patients using continuous veno-venous hemofiltration. Crit Care Med 1994; 22: 715-9.
19. Bellomo R. Continuous hemofiltration as blood purification in sepsis. New Horizons 1995; 3: 732-7.
20. Tabet JY, Lopes ME, Champagne S, Su JB, Merlet P, Hittinger L. Inflammation, cytokines and anti-inflammatory therapies in heart failure. Arch Mal Coeur Vaiss 2002; 95(3): 204-12.
21. Levine B, Kalman J, Mayer L i sur. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323: 236-41.
22. Henriksen PA, Newby DE. Therapeutic inhibition of tumour necrosis factor alpha in patients with heart failure: cooling an inflamed heart. Heart 2003; 89(1): 14-8.
23. Hakim R, Wingard RL, Parker R. Effects of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med 1994; 331: 1338-42.
24. Tortorella G, Gonzi G, Zambrelli P, Cabassi A, Borghetti A, Fiaccadori E. Continuous veno-venous hemofiltration in acute renal insufficiency and heart failure. Cardiologia 1997; 42(8): 845-8.
25. Ronco C, Bellomo R, Ricci Z. Hemodynamic response to fluid withdrawal in overhydrated patients treated with intermittent ultrafiltration and slow continuous ultrafiltration: role of blood volume monitoring. Cardiology 2001; 96(3-4): 196-201.
26. Canaud B, Leblanc M, Leray-Moragues H, Delmas S, Klouche K, Beraud JJ. Slow continuous and daily ultrafiltration for refractory congestive heart failure. Nephrol Dial Transplant 1998; 13(Suppl 4): 51-5.
27. Canaud B, Cristol JP, Klouche K i sur. Slow continuous ultrafiltration: a means of unmasking myocardial functional reserve in end-stage cardiac disease. Contrib Nephrol 1991; 93: 79-85.
28. Manns MK, Sigler MH, Teehan BP. Advantages of continuous veno-venous hemodialysis (CVVHD) in acute renal failure. J Am Soc Nephrol 1995; 6: 470.